HematologyNews.net

Hematology Xagena

Search results for "Deep vein thrombosis"

Initial clinical results from Pivotal Phase III Special Protocol Assessment ( SPA ) trials using Revlimid ( Lenalidomide ) as a new approach in the treatment of heavily pretreated patients with relaps ...


Researchers from the University of Bologna, Italy, demonstrate that Thal-Dex ( Thalidomide used in combination with Dexamethasone ) is more powerful than conventional chemotherapy for the treatment of ...


The combination of Thalidomide and Dexamethasone ( Thal/Dex ), when used as initial therapy for multiple myeloma, slowed disease progression almost two-fold compared to Dexamethasone alone. Mayo Cli ...


The FDA ( Food and Drug Administration ) has approved Xarelto ( Rivaroxaban ) to reduce the risk of blood clots, deep vein thrombosis, and pulmonary embolism following knee or hip replacement surgery. ...


New pooled safety data from the RE-COVER and RE-COVER II phase III trials in acute deep vein thrombosis ( DVT ) and pulmonary embolism ( PE ) consistently favour treatment with Pradaxa ( Dabigatran et ...


Peripherally inserted central catheters ( PICCs ) are associated with an increased risk of venous thromboembolism. However, the size of this risk relative to that associated with other central venous ...


The results from the global phase 3 Hokusai-VTE study of 8,292 patients with either acute symptomatic deep vein thrombosis ( DVT ), pulmonary embolism ( PE ), or both, were presented at the ESC Congre ...


The FDA ( Food and Drug Administration ) has approved a Supplemental New Drug Application ( sNDA ) for Eliquis ( Apixaban ) for the treatment of deep vein thrombosis ( DVT ) and pulmonary embolism ( P ...


The results from the STRATUS trial ( MM-010 ), a single-arm phase IIIb study of Pomalidomide ( Imnovid, Pomalyst ) plus low-dose Dexamethasone in patients with relapsed and refractory multiple myeloma ...


Final data from a phase 2 comparator-controlled study evaluating the incidence of venous thromboembolic events ( VTE ) in patients treated with ISIS-FXI Rx undergoing total knee replacement surgery, o ...